Lending a Helping Hand to People in Need
At Novartis, we are proud that through innovation, we are discovering and manufacturing medicines that are prescribed to millions of people. We have made a commitment to helping those in need access our medicines.
Support for Uninsured Patients
The Novartis Patient Assistance Foundation, Inc. (PAF) provides assistance to patients experiencing financial hardship who have no third-party insurance coverage for their medicines. Last year alone, the Novartis PAF provided $500 million in free medication to 100,000 patients in the United States.
If you have a financial hardship and no prescription drug coverage, then you may be eligible to receive your Novartis medicines for free.
To be eligible for Novartis PAF, you must:
- Be a US resident
- Meet income criteria, which vary by medication, and must provide proof of income1
- Not have private or public prescription coverage1
Financial eligibility program requirements are 250% to 500% of the Federal Poverty Level (FPL), depending on the Novartis Medicine.2
The Federal Poverty Level defines the minimum yearly income that a person or family needs in order to provide for its basic needs. It is adjusted each year by the Department of Health and Human Services (HHS). This level dictates a set of guidelines for use for administrative purposes — for instance, determining financial eligibility for certain federal programs.1
FPL=Federal Poverty Level
These thresholds pertain to patients in the 48 contiguous states and Washington D.C. Household income limits for patients living in Alaska and Hawaii are higher
- Exception Process exists
- Criteria based on 2013 Federal Poverty guidelines
- Based on adjusted growth income Disclaimer
Patient Assistance Foundation (PAF) services support and Novartis Pharmaceuticals Corporation do not guarantee success in obtaining reimbursement, nor do we submit appeals on behalf of providers or patients. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved by PAF services staff.
Additional support is available for Novartis Oncology Medications. Click here for more information
For more information on program application and enrollment, visit www.pap.novartis.com
Questions? Contact us:
Novartis Patient Assistance Foundation, Inc.
Support for Patients with Insurance
If you have been prescribed a Novartis medicine and need help navigating your insurance coverage, then we offer programs that may help guide you. Our programs provide help with the reimbursement process for certain Novartis oncology products and specialty products. Some programs may help patients who cannot afford their co-pay costs.
These programs include:
- Novartis Patient Assistance Now Oncology (PANO): 1-800-282-7630
- Novartis Transplant Forward: 1-877-952-1000
Exjade® (deferasirox) tablets for oral suspension Prescribing Information including Boxed WARNING
EPASS™ Advantage: 1-888-903-7277
Extavia® (interferon beta-1b) injection Prescribing Information
Extavia® Go Program: 1-866-925-2333
Ilaris® (canakinumab subcutaneous) injection Prescribing Information
Ilaris® Patient Support Program: 1-866-972-8315
TOBI® (tobramycin inhalation solution) and TOBI® PodhalerTM (tobramycin inhalation powder) Prescribing Information
TOBI CARETM PodCare+TM : 1-877-999-8624
Gilenya™ (fingolimod) capsules Prescribing Information
Gilenya™ Go Program: 1-877-408-4974
Reimbursement services support and Novartis Pharmaceuticals Corporation do not guarantee success in obtaining reimbursement, nor do we submit appeals on behalf of providers or patients. Third-party payment for medical products and services is affected by numerous factors, not all of which can be anticipated or resolved by Reimbursement services staff.
Co-Pay Assistance through Independent Charitable Foundations
Financial assistance may be available from Independent Charitable Foundations for qualified patients who are unable to afford their co-pay costs. Below is a list of foundations that may be able to provide financial support:
American Transplant Foundation
Chronic Disease Fund (CDF)
Leukemia & Lymphoma Society
National Organization for Rare Disorders (NORD)
Patient Access Network Foundation
Patient Advocate Foundation
Patient Services, Inc.
The organizations and Web sites listed above are independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for any information they may provide.
Additional information and support can be found at:
Partnership for Prescription Assistance (PPA)*: PPA is a single point of access to public and private patient assistance programs that offer more than 2500 medicines from Novartis and other pharmaceutical companies. The mission is to increase awareness of patient assistance programs and boost enrollment of those who are eligible. To access the PPA by phone, you can call toll-free, 1-888-4PPA-NOW (1-888-477-2669) or view online at www.pparx.org
Medicare Part D: If you have health care coverage through Medicare, you may also be eligible for prescription drug coverage through the Medicare Part D benefit. For more information, please call 1-800-MEDICARE (1-800-633-4227) or go to www.medicare.gov